BioMed Research International / 2016 / Article / Tab 3

Clinical Study

The Hip Functional Retrieval after Elective Surgery May Be Enhanced by Supplemented Essential Amino Acids

Table 3

Demographic, anthropometric variables, nutritional intakes, biohumoral variables, and clinical-functional test of the admitted patients after randomization.

PlaceboEAAs

Age (yrs)65.6 ± 9.5067.9 ± 7.30.2
M/F10/2014/160.3
Body weight (kg)73.0 ± 12.275.9 ± 15.90.3
Body mass index (BMI) 27.5 ± 3.929.8 ± 4.20.07
Time from index event (days)16.0 ± 1.117.9 ± 1.2<0.05
Length of stay (days)15.2 ± 1.217 ± 0.8<0.08
Daily nutritional intakes
Energy (kcal)1980 ± 2852210 ± 4410.3
kcal/kg27.1 ± 2.129.1 ± 4.330.5
Carbohydrates (g/kg)3.7 ± 0.44.1 ± 0.80.8
Proteins (g/kg)1.1 ± 0.40.9 ± 0.20.6
Lipids (g/kg)0.95 ± 0.251.15 ± 0.400.8
Blood biohumoral variables
Glucose (mg/dL; n.v. 70–110)82.2 ± 16.587.0 ± 15.50.6
Urea (mg/dL; n.v. 16–38)34.7 ± 10.935.7 ± 8.10.2
Creatinine (mg/dL; n.v. 0.6–1.1)0.73 ± 0.080.74 ± 0.090.2
Erythrocyte sedimentation rate (mm/1 hr; n.v.: <12)45.3 ± 24.249.4 ± 280.4
C-reactive protein (mg/dL; n.v. <0.8)16.4 ± 11.720.5 ± 18.10.5
Hemoglobin (g/dL; n.v. >13 males and >12 females)10.4 ± 1.210.5 ± 0.960.1
Ferritin (ng/mL; n.v. 30–230 males and 10–120 females)206.7 ± 166288 ± 2120.3
Transferrin (mg/dL; n.v. 180–240)215 ± 34191 ± 29<0.04
Albumin (g/dL; n.v. 3.5–5.5)3.62 ± 03.57 ± 0<0.07
Total protein (g/dL; n.v. 6–8) 6.37 ± 0.516.1 ± 0.38<0.04
1-globulin (% total protein; n.v. 2.9–4.9)6.7 ± 1.16.97 ± 1.380.1
2-globulin (% total protein; n.v. 7.1–11.8)11.9 ± 2.511.1 ± 2.40.1
Clinical-functional test
Harris hip score 39.78 ± 4.8941.8 ± 1.150.9

Data are expressed as mean ± standard deviation. Normal value.
Statistical analysis:
(a) unpaired -test;
(b) Chi-square test;
(c) Mann-Whitney test.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.